Upregulation of the AR-SCAP-SREBP1/2-HMGCR/CYP17A1 Axis Is Associated With Poor Survival in Both Mycn-Amplified and Mycn-Non-Amplified NB. This evidence concerns the gene MYCN and neuroblastoma.